Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
BUDA JUICE INC (BUDA)
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-11-04
$6.55-1.06%
Close 2026-11-05 · 1-day change
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
0.20 → 0.20 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BUDA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve positive free cash flow | A supporting condition in BUDA JUICE INC's published investment case. The stated target is >= $1 million. | Intact | falls below $0 free cash flow next year | Free cash flow: $-835,000 FY2026-Q2; GAAP. Published target: >= $1 million. Target period is not explicitly aligned with this observation. Aug 14, 2026-835,000 USD · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
BUDA is a smaller-cap Consumer Staples name with a durable valuation premium, but the evidence supports a fragile rather than clearly durable-compounder thesis today. Management is rated stable, while overall evidence confidence is low and risk is high.
BUDA trades at a sizable premium to peers, which the evidence links to expectations of durability. The valuation is expensive, though the fragility rating is low because the snapshot does not show the full combination of expensive valuation, weak fundamentals, and turbulent conditions.
Near term, recent performance has fallen from the top half to the bottom half of its industry, and the thesis has weakened despite a recent shift in the signal from mixed to mildly favorable. An earnings report was in line in May, but the snapshot also notes misses across recent quarters; management is stable, and near-term risk is rated quiet with a 34% miss probability.
Over the next few quarters, weaker jobs data could raise recession concerns and weigh on cyclical businesses, while continued strength in KO, PEP, and MNST could support sector momentum. Misses or lower guidance from those sector bellwethers could remove that tailwind; BUDA’s own execution and sustained improvement in relative performance also matter to the multi-year thesis.
Over a 1 to 3 year view, BUDA’s thesis is weakened, with a high peer valuation and uneven recent fundamentals offset by stable management and a sector tailwind that could persist. The evidence is limited, so the key question is whether execution improves while the sector backdrop holds. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in BUDA JUICE INC's published investment case. The stated target is >=15%. |
| Under Pressure |
| falls below 12% profit margin next fiscal year |
Net margin: 10.43% FY2026-Q2; GAAP. Published target: >=15%. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 202610.425909 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain revenue growth above 20% | A primary condition in BUDA JUICE INC's published investment case. The stated target is >=20% YoY. | Intact | falls below 20% YoY revenue growth next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.35 → $0.20 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-03 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-04 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-05 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-06 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-07 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-08 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-09 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-10 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-11 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-12 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-13 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-14 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-15 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-16 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-17 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-18 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-19 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-20 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-21 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-22 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-23 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-24 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-25 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-26 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-27 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-28 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-29 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-30 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-08-31 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-01 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-02 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-03 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-04 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-05 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-06 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-07 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-08 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-09 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-10 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-11 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-12 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-13 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-14 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-15 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-16 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-17 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-18 | $0.35 | $21,200,000 | 1 / 1 |
| 2026-09-19 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-20 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-21 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-22 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-23 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-24 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-25 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-26 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-27 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-28 | $0.25 | $21,200,000 | 1 / 1 |
| 2026-09-29 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-09-30 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-01 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-02 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-03 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-04 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-05 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-06 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-07 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-08 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-09 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-10 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-11 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-12 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-13 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-14 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-15 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-16 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-17 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-18 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-19 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-20 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-21 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-22 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-23 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-24 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-25 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-26 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-27 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-28 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-29 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-30 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-10-31 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-11-01 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-11-02 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-11-03 | $0.20 | $20,800,000 | 1 / 1 |
| 2026-11-04 | $0.20 | $20,800,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.